Hadean Ventures
2 rounds tracked since 9 July 2025.
- Rounds
- 2
- Led
- 0
- Capital in these rounds
- $120M
Sectors
Countries
Rounds
- Step PharmaClinical-stage biotech developing CTPS1 inhibitor dencatistat for cancers $44.2MSeries C · 15 Oct
- ActitheraDevelops radioligand cancer therapies targeting fibroblast activation protein (FAP). $75.5MSeries A · 9 Jul
No round matches these filters.